Stroke Management: Expanded Therapeutic Window Based on Viable Brain Analysis
Advanced brain imaging is expanding stroke treatment windows, enabling selected patients beyond 24 hours to benefit from thrombectomy or alteplase
Injury Care Solutions Group Experts:
1. Neurologist
2. Neuro-intensivist
3. Emergency Room Physician
4. Emergency Room Nurse Practitioner
5. Emergency Room Nursing
6. Medical-Surgical Nursing
7. Neuro-radiologist
8. Interventional Radiologist
9. Endovascular Neurosurgeon
10. Physical Medicine and Rehabilitation: Life Care Planners
Study by Dr. Amir Shaban: “Mechanical thrombectomy for large vessel occlusion strokes beyond 24 hours”
“Mechanical thrombectomy beyond 24 hours appears to be safe and tolerable with no more hemorrhages or complications compared with standard of care thrombectomy. Outcomes and mortality in this time window are worse compared with an earlier time window, but the rates of good outcomes may justify this therapy in selected patients.”
Study by Dr. Ying Zhou, Ph.D.: “Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours”
“Interventions: Patients were randomly assigned (1:1) … to receive intravenous alteplase or standard medical treatment.
The primary efficacy outcome was functional independence, defined as a modified Rankin Scale score of 0 to 1 at 90 days. Safety outcomes included symptomatic intracranial hemorrhage within 36 hours and all-cause mortality within 90 days.
Greater odds of a better functional outcome among the alteplase group."
To learn more, visit our website.
To read more about Stroke Management, click here.
Contact Dr. Greg Vigna, MD, JD, Board Certified PM&R, Life Care Planner: 1-800-269-6514
1. Man, et al. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients with Acute Ischemic Stroke. JAMA. 2020 Jun 2,323(21):2170-2184.
2. Shaban, et al. Mechanical thrombectomy for large vessel occlusion strokes beyond 24 hours. Journal of NeuroInterventional Surgery. Vol. 15, Issue e3.
3. Zhou, et al. Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours. The HOPE Randomized Clinical Trial. JAMA. Vol. 334, No. 9.
Greg Vigna
Injury Care Solutions Group
+1 817-809-9023
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
